Fundz

Geneticure receives $1M from Xcellerant Ventures to advance precision medicine and establish a new clinical lab in Arizona.

PRIVATEOct 21, 2026

Amount Raised

$1 Million

Round Type

Series A

ScottsdaleBiotechnologyHealth Care

Investors

Xcellerant Ventures

Description

Xcellerant Ventures announced a $1 million investment in Geneticure to support the company's growth in precision medicine. The funding will help establish a new clinical laboratory in Arizona, enhancing the state's biotech hub. Geneticure focuses on predictive testing for resistant hypertension treatments. This investment will accelerate commercial scaling and support clinical validation efforts.

Quick answer

Geneticure raised $1 Million in a Series A round, dated October 21, 2026. Investors: Xcellerant Ventures. Geneticure is based in Scottsdale, Arizona, United States.

How much did Geneticure raise?
Geneticure raised $1 Million in a Series A round on October 21, 2026.
Who invested in Geneticure?
Xcellerant Ventures is named as investors in this round.
What does Geneticure do?
Geneticure is a precision medicine company with operations in Arizona and Minnesota.
Where is Geneticure based and how big is it?
Geneticure is based in Scottsdale, Arizona, United States. Fundz records about 11 employees.
Who are the decision-makers at Geneticure?
Fundz holds 2 contacts at Geneticure, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Geneticure that raised within 45 days of this round, from Fundz verified event records.

  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
  • Neurosterix raised $105M (Series B) on November 11, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.

Who to call at Geneticure, and when

A new round usually means Geneticure is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Geneticure raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Geneticure, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Geneticure. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Geneticure

Location

Scottsdale, Arizona, United States

About

Geneticure is a precision medicine company with operations in Arizona and Minnesota. Its patented genetic tests help physicians predict patient response to hypertension treatments, including medication selection and renal denervation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Geneticure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsScott, CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Geneticure's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Geneticure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.